Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
110 studies found for:    Open Studies | "Pituitary Diseases"
Show Display Options
Rank Status Study
21 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
22 Recruiting Somatostatin Analogue Treatment of Acromegaly: Molecular Aspects
Conditions: Acromegaly;   Somatostatin;   Metabolism;   Signal Transduction
Intervention: Drug: GH
23 Recruiting Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Condition: Acromegaly
Intervention:
24 Recruiting Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors
Conditions: Hypopituitarism;   Hypogonadism;   Thyroid Dysfunction;   Bone Diseases, Metabolic
Intervention:
25 Recruiting Safety and Efficacy of LCI699 in Cushing's Disease Patients.
Condition: Cushing's Disease
Intervention: Drug: LCI699
26 Recruiting Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Conditions: Pituitary Adenoma;   Pituitary Tumor
Intervention:
27 Unknown  Androgen Replacement Therapy in Women With Hypopituitarism
Condition: Hypopituitarism
Intervention: Drug: TheraDerm
28 Recruiting Treatment of Cushing's Disease With R-roscovitine
Condition: Cushings Disease
Intervention: Drug: R-roscovitine
29 Recruiting Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment
Conditions: Hyperprolactinemia;   Insulin Resistance
Intervention: Other: Cabergoline
30 Unknown  A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Condition: Acromegaly
Intervention: Other: OGTT
31 Recruiting IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly
Condition: Acromegaly
Intervention:
32 Recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Conditions: Abnormalities;   Craniopharyngioma;   Cushing's Syndrome;   Endocrine Disease;   Pituitary Neoplasm
Intervention:
33 Unknown  Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA and ISS in Children
Conditions: Growth Hormone Deficiency;   Turner Syndrome;   Chronic Renal Failure;   Small for Gestational Age;   Idiopathic Short Stature
Intervention:
34 Not yet recruiting Implementation Study of the Peer-to-Peer Program for Patients With Diabetes
Condition: Diabetes Insipidus
Intervention:
35 Recruiting Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study
Condition: Diabetes Insipidus
Intervention:
36 Recruiting Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON
Conditions: Polycystic Ovary Syndrome;   Endometriosis;   Hyperprolactinemia
Intervention: Other: Fertility treatment
37 Recruiting A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders
Conditions: Sexual Dysfunction;   Hyperprolactinemia
Interventions: Drug: Aripiprazole;   Drug: risperidone or paliperidone
38 Unknown  Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
Conditions: Hyperprolactinemia;   Weight Gain;   Dyslipidemia
Intervention: Drug: Abilify  (aripiprazole)
39 Unknown  Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)
Conditions: Acromegaly;   Type 2 Diabetes Mellitus
Interventions: Other: oral glucose tolerance test;   Other: Subcutaneous administration of recombinant human IGF-1
40 Unknown  Expression Profile of Somatostatin Receptors and Dopamine Receptor 2 in Non-functioning Pituitary Adenomas and Resistant Prolactinomas: Correlation With in Vivo Response to Pasireotide and Cabergoline
Conditions: Non-functioning Pituitary Adenomas;   Prolactinomas
Interventions: Drug: Pasireotide;   Drug: cabergoline

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years